288 related articles for article (PubMed ID: 32801699)
1. Recent Advances in Designing 5-Fluorouracil Delivery Systems: A Stepping Stone in the Safe Treatment of Colorectal Cancer.
Entezar-Almahdi E; Mohammadi-Samani S; Tayebi L; Farjadian F
Int J Nanomedicine; 2020; 15():5445-5458. PubMed ID: 32801699
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of 5-fluorouracil encapsulated in zeolites as drug delivery systems for in vitro models of colorectal carcinoma.
Vilaça N; Amorim R; Machado AF; Parpot P; Pereira MF; Sardo M; Rocha J; Fonseca AM; Neves IC; Baltazar F
Colloids Surf B Biointerfaces; 2013 Dec; 112():237-44. PubMed ID: 23988779
[TBL] [Abstract][Full Text] [Related]
3. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
4. Strategy for chemotherapeutic delivery using a nanosized porous metal-organic framework with a central composite design.
Li Y; Li X; Guan Q; Zhang C; Xu T; Dong Y; Bai X; Zhang W
Int J Nanomedicine; 2017; 12():1465-1474. PubMed ID: 28260892
[TBL] [Abstract][Full Text] [Related]
5. Bacterial Ghosts Carrying 5-Fluorouracil: A Novel Biological Carrier for Targeting Colorectal Cancer.
Youssof AME; Alanazi FK; Salem-Bekhit MM; Shakeel F; Haq N
AAPS PharmSciTech; 2019 Jan; 20(2):48. PubMed ID: 30617674
[TBL] [Abstract][Full Text] [Related]
6. Poly(3-hydroxybutyrate-CO-3-hydroxyvalerate) PHBHV biocompatible nanocarriers for 5-FU delivery targeting colorectal cancer.
Radu IC; Hudita A; Zaharia C; Galateanu B; Iovu H; Tanasa EV; Georgiana Nitu S; Ginghina O; Negrei C; Tsatsakis A; Velonia K; Shtilman M; Costache M
Drug Deliv; 2019 Dec; 26(1):318-327. PubMed ID: 30896267
[TBL] [Abstract][Full Text] [Related]
7. The Potential Anticancer Activity of 5-Fluorouracil Loaded in Cellulose Fibers Isolated from Rice Straw.
Yusefi M; Shameli K; Jahangirian H; Teow SY; Umakoshi H; Saleh B; Rafiee-Moghaddam R; Webster TJ
Int J Nanomedicine; 2020; 15():5417-5432. PubMed ID: 32801697
[TBL] [Abstract][Full Text] [Related]
8. Assam Bora rice starch based biocompatible mucoadhesive microsphere for targeted delivery of 5-fluorouracil in colorectal cancer.
Ahmad MZ; Akhter S; Anwar M; Ahmad FJ
Mol Pharm; 2012 Nov; 9(11):2986-94. PubMed ID: 22994847
[TBL] [Abstract][Full Text] [Related]
9. Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study.
Puri R; Jain S
Anticancer Drugs; 2012 Oct; 23(9):923-34. PubMed ID: 22926258
[TBL] [Abstract][Full Text] [Related]
10. Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer: Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model.
Safwat MA; Soliman GM; Sayed D; Attia MA
Mol Pharm; 2018 Jun; 15(6):2194-2205. PubMed ID: 29701979
[TBL] [Abstract][Full Text] [Related]
11. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
12. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
Li X; Xu Y; Chen G; Wei P; Ping Q
Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
[TBL] [Abstract][Full Text] [Related]
13. Biomodulation of Fluorouracil in colorectal cancer.
Ardalan B; Luis R; Jaime M; Franceschi D
Cancer Invest; 1998; 16(4):237-51. PubMed ID: 9589033
[TBL] [Abstract][Full Text] [Related]
14. 5-Fluorouracil nano-delivery systems as a cutting-edge for cancer therapy.
Valencia-Lazcano AA; Hassan D; Pourmadadi M; Shamsabadipour A; Behzadmehr R; Rahdar A; Medina DI; Díez-Pascual AM
Eur J Med Chem; 2023 Jan; 246():114995. PubMed ID: 36493619
[TBL] [Abstract][Full Text] [Related]
15. Gold nanoparticles enhance 5-fluorouracil anticancer efficacy against colorectal cancer cells.
Safwat MA; Soliman GM; Sayed D; Attia MA
Int J Pharm; 2016 Nov; 513(1-2):648-658. PubMed ID: 27693737
[TBL] [Abstract][Full Text] [Related]
16. Where do we stand with 5-fluorouracil?
Schmoll HJ; Büchele T; Grothey A; Dempke W
Semin Oncol; 1999 Dec; 26(6):589-605. PubMed ID: 10606252
[TBL] [Abstract][Full Text] [Related]
17. Intravenous and intra-arterial oxygen-15-labeled water and fluorine-18-labeled fluorouracil in patients with liver metastases from colorectal carcinoma.
Dimitrakopoulou-Strauss A; Strauss LG; Schlag P; Hohenberger P; Irngartinger G; Oberdorfer F; Doll J; van Kaick G
J Nucl Med; 1998 Mar; 39(3):465-73. PubMed ID: 9529293
[TBL] [Abstract][Full Text] [Related]
18. Alternating bolus and continuous infusion 5-fluorouracil: a strategy to overcome resistance to this fluoropyrimidine in advanced colorectal cancer patients.
Guglielmi A; Aschele C; Grossi F; Tixi L; Sobrero A
Cytotechnology; 1996; 19(3):215-9. PubMed ID: 8862009
[TBL] [Abstract][Full Text] [Related]
19. Microprocessor-controlled iontophoretic drug delivery of 5-fluorouracil: pharmacodynamic and pharmacokinetic study.
Chandrashekar NS; Shobha Rani RH
J BUON; 2007; 12(4):529-34. PubMed ID: 18067212
[TBL] [Abstract][Full Text] [Related]
20. [5-fluorouracil].
Aiba K
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1368-79. PubMed ID: 11681244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
